Business Context and Reporting Period
Company: SkinHealth Systems Inc. (formerly The Beauty Health Company)
Filing Type: Form 10-Q (Quarterly Report)
Reporting Period: Three and six months ended June 30, 2026
Business Overview: A global medical aesthetics company anchored by the Hydrafacial treatment, offering delivery systems and consumables. The company rebranded from "The Beauty Health Company" to "SkinHealth Systems Inc." in April 2026.
Key Financial Metrics
| Metric (in thousands) | Q2 2026 | Q2 2025 | YTD 2026 | YTD 2025 |
|---|---|---|---|---|
| Net Sales | $72,113 | $78,187 | $137,023 | $147,767 |
| Gross Profit | $49,338 | $49,112 | $93,777 | $97,692 |
| Gross Margin | 68.4% | 62.8% | 68.4% | 66.1% |
| Operating Income (Loss) | $3,572 | $(2,700) | $1,771 | $(14,723) |
| Net Income (Loss) | $(2,669) | $19,712 | $(9,299) | $9,616 |
| Diluted EPS | $(0.02) | $0.03 | $(0.07) | $(0.02) |
| Cash & Equivalents (End of Period) | $206,074 (as of June 30, 2026) | |||
| Convertible Debt (Net) | $345,209 (Total); $103,089 (Current) |
Material Changes vs. Prior Period
- Revenue Decline: Net sales decreased 7.8% in Q2 2026 and 7.3% YTD compared to 2025. Delivery Systems sales dropped 18.4% (Q2) and 13.6% (YTD) due to unfavorable macroeconomic and credit conditions. Consumables sales declined 3.5% (Q2) and 4.7% (YTD).
- Profitability Improvement: Despite revenue declines, the company returned to operating profitability in Q2 2026 ($3.6M) compared to a loss in Q2 2025. Gross margin expanded to 68.4% from 62.8% in Q2 2025, driven by lower product costs and the absence of inventory charges seen in the prior year.
- Expense Reduction: Total operating expenses decreased 11.7% in Q2 and 18.1% YTD. General and Administrative expenses dropped significantly (15.0% Q2, 25.8% YTD) due to lower personnel costs, legal fees, and share-based compensation, partially offset by costs related to a securities class action settlement.
- Net Loss vs. Prior Year Gain: The company reported a net loss of $2.7M in Q2 2026, contrasting with a net income of $19.7M in Q2 2025. The prior year's income was significantly boosted by an $18.1M net gain from the exchange and repurchase of convertible notes, which did not recur in the current period.
- Debt Restructuring: Interest expense increased 51.9% in Q2 due to the issuance of 7.95% Convertible Senior Secured Notes due 2028, replacing lower-interest 2026 Notes.
Guidance, Outlook, Risks, and Contingencies
- Legal Settlements:
- Securities Class Action: Reached a tentative settlement in principle for $18.0M total. The Company is responsible for $3.0M from its own funds; $15.0M is expected to be covered by insurance. Subject to court approval.
- Customer Class Action: Reached a settlement-in-principle regarding Syndeo machine defects. Preliminary court approval granted; final hearing set for December 4, 2026.
- Derivative Action: Entered a Stipulation of Settlement regarding fiduciary duty claims. Awaiting court approval following a hearing in May 2026.
- SEC Investigation: The Company is cooperating with an ongoing SEC formal investigation related to the allegations in the Securities Class Action. Duration and outcome are unpredictable.
- Nasdaq Listing Compliance: Received notice of non-compliance with Nasdaq Minimum Bid Price Requirement (stock price below $1.00 for 30 consecutive days). Filed a preliminary proxy statement seeking stockholder approval for a reverse stock split (ratio 1-for-5 to 1-for-20) to regain compliance.
- Market Strategy: Transitioned sales in Australia and New Zealand to a distributor partner in June 2026, discontinuing direct sales in the region to improve long-term profitability.
- Liquidity: Management believes current cash ($206.1M) is sufficient for operations for at least the next 12 months. The company intends to repay the 2026 Notes maturity with cash on hand by the end of Q3 2026.
Investor Verification Checklist
- Settlement Finality: Verify court approval status for the $18M Securities Class Action settlement and the Customer Class Action settlement to confirm the $3M cash outflow liability.
- Reverse Stock Split: Monitor stockholder vote results on the proposed reverse stock split to assess the risk of delisting from Nasdaq.
- Debt Maturity: Confirm the company's ability to repay the $103M current portion of convertible notes due in late 2026 using existing cash reserves.
- Revenue Trends: Assess whether the decline in Delivery Systems sales is stabilizing or if macroeconomic headwinds will persist into the second half of 2026.
- SEC Investigation: Monitor for any updates regarding the scope or potential penalties of the ongoing SEC investigation.